Switzerland · Series A startup

Who invested in Cimeio Therapeutics

One round we have observed, with the one investor named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Pharma

Funding summaryUpdated 26 Oct 2026

$50Mraised across 1 round since 2022, from 1 source

Latest round
Series A, $50MApr 2022
Investors
1
See who backed them

The rounds

  1. Apr 2022
    Series A$50M

    Source recorded

Founders and team

From Cimeio Therapeutics's own website: 1 on the team.

  • Nikita SharmaHead of Business Development

Everyone who backed them

Versant VenturesVC firm1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Cimeio Therapeutics

Who invested in Cimeio Therapeutics?

Cimeio Therapeutics's investors include Versant Ventures.

How much has Cimeio Therapeutics raised?

Cimeio Therapeutics has raised $50M across 1 round since 2022.

When did Cimeio Therapeutics last raise?

Cimeio Therapeutics's most recent round was a Series A of $50M in Apr 2022.

What was Cimeio Therapeutics's biggest round?

Its most recent round, $50M in Apr 2022, is also its largest on record.

Who backed Cimeio Therapeutics first?

Cimeio Therapeutics's first round on record, in Apr 2022, was backed by Versant Ventures.

What stage is Cimeio Therapeutics at?

Cimeio Therapeutics's latest named round is a Series A, in Apr 2022.

Where is Cimeio Therapeutics based?

Cimeio Therapeutics is based in Switzerland.

Companies like Cimeio Therapeutics

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.